Let people most affected by gene editing write CRISPR rules
By Jessica Hamzelou,
New Scientist
| 04. 29. 2016
Untitled Document
Who stands to benefit from – or lose out on – gene editing? Advances in our ability to tweak the human genome using CRISPR Cas-9 and similar techniques won’t only affect those at risk of genetic disorders. Women and disabled people are likely to be disproportionately affected. And people living in poor countries – who are at the greatest risk of disease – could miss out on the benefits.
These were among the points raised at a summit held by the US National Academies of Science and Medicine’s Committee on Human Gene Editing in Paris today. The committee will draw up a set of recommendations based on the questions and comments raised by the audience – a mix of scientists, ethicists and lawyers.
The CRISPR editing tool offers scientists a way to cut out sections of DNA and potentially replace them with others. Since it took the research world by storm last year, some have suggested it could be used to treat genetic disorders by precisely targeting the responsible genetic mutation. Disorders like Duchenne muscular dystrophy, which causes...
Related Articles
By Emma McDonald Kennedy
| 09.25.2025
In the leadup to the 2024 election, Donald Trump repeatedly promised to make IVF more accessible. He made the commitment central to his campaign, even referring to himself as the “father of IVF.” In his first month in office, Trump issued an executive order promising to expand IVF access. The order set a 90-day deadline for policy recommendations for “lowering costs and reducing barriers to IVF,” although it didn’t make any substantive reproductive healthcare policy changes.
The response to the...
Sir Francis Galton, 1890s, by Eveleen Myers (née Tennant)
npg.org
Public Domain via Wikipedia
As has been discussed in recent issues of Biopolitical Times (1, 2), there are, increasingly, companies that claim to be selling parents better babies by selecting the “best” embryos. These services don’t come cheap – think $50,000, or even more, for embryo testing, plus perhaps as much again for IVF and concomitant services. To most of us, that is extremely expensive...
By Margaux MacColl, The San Francisco Standard | 09.17.2025
Designer babies are coming soon to an IVF clinic near you.
Nucleus Genomics, founded by Kian Sadeghi in 2020, when he was just 20, got its start analyzing genomes to weigh a person’s risk of everything from cancer to ADHD...
By Marianne Lamers, NEMO Kennislink [cites CGS' Katie Hasson] | 09.23.2025
Een rijtje gespreide vulva’s gaapt de bezoeker aan. Zó ziet een bevalling eruit, en zó een baarmoeder met foetus. Een zwangerschap, maar dan zonder zwangere vrouw, gestript van zorgen, gêne en pijn. De zwangerschapsmodellen en oefenbekkens, te zien in de...